Scientists worldwide have confirmed that dogs can accurately detect can.cer in human samples using their powerful sense of smell. They identify volatile organic compounds (VOCs) released when can.cerous cells are present — detectable in breath, urine, and even tumors, sometimes in early stages.
Multiple studies have shown promising results. One study found dogs trained to detect breast can.cer could also identify colorectal can.cer, suggesting a common scent profile across types. In Japan, a single Labrador retriever identified all 40 breast can.cer samples correctly from urine, achieving 100% sensitivity and specificity.
These results show dogs could become noninvasive, fast, and low-cost diagnostic tools. Breath and urine samples are easy to collect, and detection is nearly immediate. However, inconsistencies in training, sample types, and methodology challenge reproducibility.
Standardized double-blind studies are needed to validate accuracy and identify the specific VOCs triggering the dogs’ responses. Researchers also hope to develop an artificial “electronic nose” based on these scent profiles.
Though not yet mainstream, dogs could become valuable allies in early can.cer detection — saving lives with every sniff.
